News
A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...
Moderna's flu vaccine shows positive late-stage trial results, paving way for combination Covid shot
The phase three study data clears the path forward for Moderna’s combination jab targeting Covid-19 and influenza.
The companies behind two of the COVID-19 vaccines authorized for emergency use in the United States have applied to the Food and Drug Administration for full approval, which would allow them to ...
The revamped and “more anti-vax skewed ACIP committee” at the CDC “has a bone to pick with mRNA vaccines,” according to ...
Moderna is preparing to test Health Secretary Robert F. Kennedy Jr.'s tougher vaccine policies with a combination flu-COVID ...
The FDA has approved its requested updated versions of expanded warning labels for COVID-19 vaccines. As Healio previously ...
The latest phase 3 win is a boost for Moderna’s attempts to create a flu/COVID combination vaccine. The company withdrew a filing for FDA approval for its combo candidate last month while it waited ...
The approval “adds an important new tool to help protect people at high risk of severe disease from COVID-19,” Stephane Bancel, Moderna CEO, said in a statement Saturday.
The Food and Drug Administration expanded the approval of Moderna’s RSV vaccine on Thursday, extending the license to include adults aged 18 to 59 who are at high risk of severe illness if they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results